Both in Surgical Instruments
Embecta vs Neuropace
Over the past year EMBC returned −53.1% and NPCE returned +23.7%; their daily moves had a correlation of 0.14.
EMBC −53.1% NPCE +23.7%Growth of $1, one year, split-adjusted
| Metric | EMBC | NPCE |
|---|---|---|
| Price | $6.25 | $12.30 |
| Market cap | $354.1M | $422.2M |
| Today | −4.73% | −5.46% |
| 1 month | +7.9% | −6.5% |
| 6 months | −32.3% | −27.9% |
| Year to date | −47.4% | −20.3% |
| 1 year | −54.0% | +21.4% |
| Revenue growth (YoY) | −8.1% | +17.1% |
| Gross margin | 56.4% | 82.8% |
| Net margin | 7.8% | −27.2% |
| P/E (TTM) | 4.0× | — |
| Price / sales | 0.3× | 4.3× |
| Net cash | -$1.27B | -$7.3M |
| Dividend yield | 0.64% | — |
| Volatility (60d) | 73.0% | 42.5% |
| Short % of float | 10.5% | 3.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).